Save information for later
Sign Up

Learn About Rasmussen Encephalitis

What is the definition of Rasmussen Encephalitis?
Rasmussen encephalitis is a chronic inflammatory neurological disease that usually affects only one hemisphere of the brain. Rasmussen encephalitis is characterized by frequent and severe seizures, loss of motor skills and speech, paralysis on one side of the body (hemiparesis), inflammation of the brain (encephalitis), and mental deterioration. While the cause of Rasmussen encephalitis is unknown, there is evidence that in many patients it is an autoimmune disorder.
What are the alternative names for Rasmussen Encephalitis?
  • Rasmussen encephalitis
  • RE
Who are the top Rasmussen Encephalitis Local Doctors?
Elite in Rasmussen Encephalitis
Elite in Rasmussen Encephalitis
Brussels, BRU, BE 

Dina Amrom practices in Brussels, Belgium. Ms. Amrom is rated as an Elite expert by MediFind in the treatment of Rasmussen Encephalitis. Her top areas of expertise are Polymicrogyria, Rasmussen Encephalitis, Subcortical Band Heterotopia, and Miller-Dieker Syndrome.

Elite in Rasmussen Encephalitis
Elite in Rasmussen Encephalitis
Bielefeld, NW, DE 

Christian Bien practices in Bielefeld, Germany. Mr. Bien is rated as an Elite expert by MediFind in the treatment of Rasmussen Encephalitis. His top areas of expertise are Encephalitis, Rasmussen Encephalitis, Epilepsy, Hashimoto Thyroiditis, and Awake Craniotomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Rasmussen Encephalitis
Elite in Rasmussen Encephalitis
9500 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English
Accepting New Patients

Elaine Wyllie is a Neurologist in Cleveland, Ohio. Dr. Wyllie is rated as an Elite provider by MediFind in the treatment of Rasmussen Encephalitis. Her top areas of expertise are Rasmussen Encephalitis, Seizures, Continuous Spike-Wave During Slow Sleep Syndrome, and Absence Seizure. Dr. Wyllie is currently accepting new patients.

What are the latest Rasmussen Encephalitis Clinical Trials?
Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term

Summary: Since the initial study of cases reported between 2009 and 2015, adalimumab has become in France the immunomodulatory reference treatment used after failure of corticosteroids and immunoglobulins before a possible recourse to the hemispherotomy. This observational study is intended to document the long-term efficacy and safety of Adalimumab therapy in patients with Rasmussen encephalitis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center